Indazoles

US7592363B2 · kind B2 · utility

Assignee

• Wyeth, LLC · US

Inventors

• Robert J. Steffan · Langhorne, US
• Edward Matelan · Royersford, US
• Stephen Bowen · Cincinnati, US
• John W. Ullrich · Schwenksville, US
• Jay E. Wrobel · Lawrenceville, US
• Edouard Zamaratski · Stockholm, SE
• Lars Krüger · Huddinge, SE
• Annabel L. Olsen Hedemyr · Stockholm, SE
• Aiping Cheng · Huddinge, SE
• Tomas Hansson · Nynäshamn, SE
• Rayomand Jal Unwalla · Eagleville, US
• Christopher Miller · Wayne, US
• Patrik Rhönnstad · Malmö, SE

Key dates

• Filing date: Aug 1, 2005
• Grant date: Sep 22, 2009
• Expiry date: Aug 1, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention provides compounds of Formula (I) or (Ia):that are useful in the treatment or inhibition of LXR mediated diseases.